Artivila Biopharma

Artivila is an AI-driven innovative drug discovery platform dedicated to addressing drug development for neurodegenerative diseases, cancer, and autoimmune diseases. The company possesses an integrated AI/CADD research and development system and a team of top-tier scientists with extensive experience (a seamless combination of AI+HI concepts) and has successfully identified lead compounds for multiple global drug targets.